About Technology Issues FAQ

Links

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.